Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2022.121 | Retrospective study comparison between types of percutanoeus catheter directed treatment on pulmonary embolism |
Prof. TAN GuangMing 譚廣明 |
| 2022.122 | Elucidating the role of RNA N1-methyladenosine modifications in colorectal cancer |
Dr. CHEN Huarong 陈华溶 |
| 2022.123 | Case report of multisystemic smooth muscle dysfunction syndrome (MSMDS) in Hong Kong | Dr Tam Catherine Wing Yan |
| 2022.124 | Focal Bone Lesions Following Ultrasound Diathermy: Case Series |
Dr. TSAI Chris Siu Chun 蔡紹俊 |
| 2022.125 | A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A Nephropathy |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2022.126 | Clinical Bioequivalence Study on Two Sitagliptin Tablet 100 mg Formulations |
Prof. ZUO Zhong 左中 |
| 2022.127 | A prospective observational study to assess serial gut microbiome and a panel of bacterial gene markers (M3) changes after endoscopic resection of colorectal advanced neoplasia |
Prof. LAU Louis Ho Shing 柳浩城 |
| 2022.128 | Microrobotic Cell Delivery for Precision Cell Therapy |
Prof. LEE Wayne Yuk Wai 李郁偉 |
| 2022.130 | A pilot study for early detection of Autism Spectrum Disorder using a machine learning approach for retinal images | Prof. ZEE Benny Chung Ying |
| 2022.131 | Adaptive versus Maladaptive Emotional Regulation in Social Contexts: A Dyadic Study Combining Sociocognitive and Physiological Measures | Dr. CHIU Chui De |
| 2022.132 | Genomics study on Hong Kong brain metastasis cancer patients | Dr. CHAN Danny Tat Ming |
| 2022.134 | Impact of cholesterol level on long-term angiographic outcome of CABG patients | Dr. WONG Randolph Hung Leung |
| 2022.135 | Ten-year follow-up of an early psychosis cohort underwent randomized controlled trial for an extended early intervention |
Dr. WONG Yip Chau 黃業就 |
| 2022.136 | Multi-modal approaches to determine digital clinical phenotyping, novel proteomic biomarkers, and microbiota-host responses of REM sleep behavior disorder, a prodromal stage of alpha-synucleinopathy neurodegeneration, in a prospective family cohort |
Prof. WING Yun Kwok 榮潤國 |
| 2022.137 | Multi-organ biobanking for REM sleep behavior disorder and alpha-synucleinopathies – towards deep understanding of pathophysiology and next generation treatment (“Silent Professor” Body Donation Program) |
Prof. WING Yun Kwok 榮潤國 |
| 2022.138 | Neuropsychiatric ‘long-COVID’ in adult patients: Part 2 (In-depth assessment) | Dr. CHAU Steven Wai Ho |
| 2022.139 | Neuropsychiatric ‘long-COVID’ in adult patients: Part 3 (MRI neuroimaging study) | Dr. CHAU Steven |
| 2022.140 | A machine-learning approach to determine retinal characteristics for COVID-19 CT value screening | Prof. ZEE Benny Chung Ying |
| 2022.141 | Using data to transform diabetes care and patient lives |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2022.142 | Institute of Medical Intelligence and Extended Reality (XR) | Prof. HENG Pheng Ann |
| 2022.143 | Family-based association study in idiopathic rapid eye movement sleep behavior disorder: a two-phase study using whole exome sequencing |
Prof. WING Yun Kwok 榮潤國 |
| 2022.145 | Effectiveness of COVID-19 vaccines in Hong Kong |
Dr. YEUNG Hoi Ting 楊凱婷 |
| 2022.146 | Reliability and validity of pre-excision gap balancing assessment in robotic total knee replacement | Dr. ONG Michael |
| 2022.147 | The Impact of excessive dietary sodium on brain health: examining a common but neglected risk factor |
Dr. LAM Bonnie Yin Ka 林賢嘉 |
| 2022.148 | A Multicenter, Double-blind, Randomized, Placebo-Controlled, Phase II/III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of JT001 (VV116) for the Early Treatment of Coronavirus Disease 2019 (COVID-19) in Participants with Mild to Moderate COVID-19 |
Dr. LUK Andrea On Yan 陸安欣 |
| 2022.149 | Ecological momentary intervention for stroke caregivers’ psychological support: a randomised controlled trial | Dr. TANG Maria Wing Sze |
| 2022.150 | Effect of JAK inhibitor on bone erosion repair in rheumatoid arthritis assessed by HR-pQCT: a randomised placebo-controlled study |
Prof. SO Ho 蘇晧 |
| 2022.151 | Osteosarcopenia Assessed by 3D High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) and fracture risk in non-osteoporotic patients with immune-mediated inflammatory disease |
Prof. TAM Lai Shan 譚麗珊 |
| 2022.152 | Combination of artificial intelligence (ENDOAID) and mucosal exposure device (ENDOCUFF) to enhance colorectal neoplasia detection: a randomized controlled trial | Prof. LAU Louis Ho Shing |
| 2022.153 | A retrospective study on effectiveness of COVID-19 vaccines based on hospitalized patients |
Prof. NG Wai Yin 吳煒燕 |
| 2022.154 | Outcomes of pregnant women with COVID-19 in Hong Kong | Prof. POON Liona Chiu Yee |
| 2022.155 | Efficacy and toxicity of abiraterone acetate and docetaxel for patients with metastatic castration-sensitive prostate cancer (mCSPC) | Dr. LAM Benjamin Heung Wing |
| 2022.156 | Review of lung abscess manifestations and outcomes in a local hospital: a 20-year retrospective study | Dr. PANG Kit Hing |
| 2022.157 | Examining the health impact of extreme hot weather on older adults who are in socioeconomic disadvantage and those who are in long-term institutional care in Hong Kong |
Dr. LAI Tsz Chun 黎子俊 |
| 2022.158 | The prevalence of Iron deficiency in Advanced Prostate Cancer Patients with Anaemia and the Impact on Patients |
Prof. NG Chi Fai 吳志輝 |
| 2022.159 | Optimization of Peritoneal Dialysis Prescription by Early Determination of Peritoneal Transport Characteristics |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2022.160 | A prospective study to evaluate the diagnostic accuracy of computer-aided diagnosis (CADx) system in real-time characterization of colorectal neoplasia | Prof. LAU Louis Ho Shing |
| 2022.161 | Assessment of liver inflammation using glucose enhanced spin-lock T1rho MRI |
Prof. CHEN Weitian 陈蔚天 |
| 2022.162 | A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2022.163 | Unraveling the regulatory effects of prodrug epigallocatechin-3-gallate on myeloid-derived suppresser cells to suppress the development of endometriosis |
Dr. ZHANG Tao 張濤 |
| 2022.164 | A Study on Outcomes of Surgical and Percutaneous Left Atrial Appendage Closure |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2022.165 | A prospective study to identify known and unknown bacterial pathogens in patients with pleural infections using a combination of conventional culture and next-generation sequencing approaches |
Dr. CHAN Ka Pang 陳嘉鵬 |
| 2022.166 | Diagnostic utility of Mycobacterium tuberculosis cell-free DNA (MTB cfDNA) in tuberculous and non-tuberculous pleural effusion |
Dr. CHAN Ka Pang 陳嘉鵬 |
| 2022.167 | Telemedicine for out-patient management of adult asthma patients, effect on quality of life and asthma control, a randomised control trial. |
Dr. KO Fanny Wai San 古惠珊 |
| 2022.168 | Instant message-delivered brief Internet-based Cognitive Behavioural Therapy (iCBT) for post-stroke depression: a mixed method study | Dr. TANG Maria Wing Sze |
| 2022.169 | The use of JAK-1/3 inhibitor (Tofacitinib) in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis – A pilot study |
Dr. CHAN Agnes Wai Sze 陳慧詩醫生 |
| 2022.170 | A prospective cross-sectional multi-center study to assess the diagnostic accuracy of a panel of bacterial gene markers (M3) for colorectal advanced neoplasia |
Prof. LAU Louis Ho Shing 柳浩城 |
| 2022.171 | A phase 3, multicenter, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of tafasitamab plus lenalidomide in addition to R-CHOP versus R-CHOP in previously untreated, high-intermediate and high-risk patients with newly-diagnosed diffuse large B-cell lymphoma (DLBCL) |
Dr. WONG Raymond Siu Ming 王紹明 |
| 2022.172 | KontRASt-02: A randomized, controlled, open label, phase III study evaluating the efficacy and safety of JDQ443 versus docetaxel in previously treated subjects with locally advanced or metastatic KRAS G12C mutant non-small cell lung cancer |
Dr. LOONG Herbert Ho Fung 龍浩鋒醫生 |
| 2022.173 | EPIK-B3: A Phase III, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of alpelisib (BYL719) in combination with nab-paclitaxel in patients with advanced triple negative breast cancer with either phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) mutation or phosphatase and tensin homolog protein (PTEN) loss without PIK3CA mutation |
Prof. YEO Winnie 楊明明教授 |
Page 223 of 288.